Dissolved and financials
CVR: 40429077
Previous names: Integra 3 08042019 IVS, Spada IVS
DKK -179,496
Gross profit
Net result: DKK -344,118
No owners listed
CVR · view owners
No management registered
CVR · view management
Dissolved
Ceased 9 August 2024
CVR · view overview
No headcount reported
Director role ended: Keld Mikael Jørgensen
CVR · 09/08/2024
View the full event history
Spada ApS was a Danish company of the type Anpartsselskab based in København S, founded in 2019. The company has been dissolved on 9 August 2024. The company was registered under the industry Detailhandel med personbiler, varebiler og minibusser. The company was previously named Spada IVS and Integra 3 08042019 IVS. In 2023, the company reported a gross profit of DKK -179,496 and a net result of DKK -344,118 compared with DKK -388,364 the year before. Equity in the 2023 report amounted to DKK -344,118.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202301/01/2023 – 31/12/2023 | -179 t. | -344 t. | 1.4 mio. | -344 t. | - | |
| 202201/01/2022 – 31/12/2022 | -251 t. | -388 t. | 1.5 mio. | -746 t. | - | |
| 202101/01/2021 – 31/12/2021 | -270 t. | -413 t. | 1.3 mio. | -358 t. | - | |
| 202001/01/2020 – 31/12/2020 | -458 t. | -501 t. | 1.2 mio. | -545 t. | - |
Screen owners and management against the Danish FSA's official PEP lists
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreNo. Spada ApS is registered in the Danish CVR register with the status Dissolved and ceased on 9 August 2024.
The CVR number of Spada ApS is 40429077.
In 2023, Spada ApS reported a gross profit of DKK -179,496.
Spada ApS was founded on 8 April 2019.
Spada ApS was registered under the industry Detailhandel med personbiler, varebiler og minibusser (industry code 451120).
Spada ApS was located at c/o Keld Mikael Jørgensen, Ørestads Boulevard 55A 8. 802, 2300 København S.
As of August 9, 2024, Keld Mikael Jørgensen has stepped down as director of Spada ApS.
Spada ApS was dissolved on August 9, 2024.
Spada ApS has published its annual report for 2023. Gross profit came to DKK -179,496, and the net result was DKK -344,118.
Spada ApS has published its annual report for 2022. Gross profit came to DKK -251,289, and the net result was DKK -388,364.
Spada ApS has published its annual report for 2021. Gross profit came to DKK -269,960, and the net result was DKK -412,730.
On October 11, 2021, the company changed its name from Spada IVS to Spada ApS.
Spada ApS has published its annual report for 2020. Gross profit came to DKK -458,180, and the net result was DKK -500,799.
Spada ApS has published its interim report for the period April 8, 2019 to December 31, 2019.
As of July 1, 2019, Keld Mikael Jørgensen is registered as director of Spada ApS.
As of July 1, 2019, Jonas Møllgaard Mikkelsen has stepped down as director of Spada ApS.
On July 1, 2019, the company changed its name from Integra 3 08042019 IVS to Spada IVS.
As of April 8, 2019, Jonas Møllgaard Mikkelsen is registered as director of Spada ApS.
Spada ApS was founded on April 8, 2019.

Uneven Bits ApS is an independent IT consultancy founded and operated by Klaus Byskov Pedersen. With deep expertise in software architecture and systems design, I help organizations build robust, scalable, and maintainable technical solutions. Whether you need strategic guidance on technology decisions, hands-on architecture work, or help navigating complex technical challenges, I bring focused expertise and a practical approach to every engagement.

Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.

Selskabets formål er at udvikle, markedsføre, sælge og implementere software produkter til brug ved indkøbsstyring og dermed efter bestyrelsens skøn beslægtet virksomhed


Selskabets formål er IT- og kommunikationsvirksomhed samt virksomhed i øvrigt, der efter bestyrelsens skøn står i forbindelse hermed.